JPMorgan Chase & Co’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67 | Hold |
227
| – | – | ﹤0.01% | 5986 |
|
|
2025
Q1 | $69 | Hold |
227
| – | – | ﹤0.01% | 6045 |
|
|
2024
Q4 | $653 | Hold |
227
| – | – | ﹤0.01% | 5723 |
|
|
2024
Q3 | $583 | Hold |
227
| – | – | ﹤0.01% | 5717 |
|
|
2024
Q2 | $445 | Hold |
227
| – | – | ﹤0.01% | 5675 |
|
|
2024
Q1 | $604 | Sell |
227
-40
| -15% | -$106 | ﹤0.01% | 5678 |
|
|
2023
Q4 | $1.11K | Buy |
267
+25
| +10% | +$104 | ﹤0.01% | 5787 |
|
|
2023
Q3 | $334 | Buy |
242
+15
| +7% | +$21 | ﹤0.01% | 5818 |
|
|
2023
Q2 | $711 | Sell |
227
-110
| -33% | -$345 | ﹤0.01% | 5597 |
|
|
2023
Q1 | $1K | Buy |
337
+109
| +48% | +$323 | ﹤0.01% | 5660 |
|
|
2022
Q4 | $1K | Sell |
228
-391
| -63% | -$1.72K | ﹤0.01% | 5465 |
|
|
2022
Q3 | $5K | Buy |
619
+203
| +49% | +$1.64K | ﹤0.01% | 5191 |
|
|
2022
Q2 | $5K | Sell |
416
-638
| -61% | -$7.67K | ﹤0.01% | 5308 |
|
|
2022
Q1 | $18K | Buy |
1,054
+275
| +35% | +$4.7K | ﹤0.01% | 5280 |
|
|
2021
Q4 | $25K | Buy |
+779
| New | +$25K | ﹤0.01% | 5275 |
|
|
2021
Q1 | – | Sell |
-4,086
| Closed | -$92K | – | 5317 |
|
|
2020
Q4 | $92K | Buy |
4,086
+4,084
| +204,200% | +$92K | ﹤0.01% | 4321 |
|
|
2020
Q3 | $0 | Sell |
2
-54,916
| -100% | – | ﹤0.01% | 4912 |
|
|
2020
Q2 | $1.15M | Buy |
+54,918
| New | +$1.15M | ﹤0.01% | 2938 |
|
|
2018
Q4 | – | Sell |
-1,426
| Closed | -$111K | – | 4918 |
|
|
2018
Q3 | $111K | Buy |
+1,426
| New | +$111K | ﹤0.01% | 4077 |
|
|
2018
Q2 | – | Sell |
-4,050
| Closed | -$336K | – | 4795 |
|
|
2018
Q1 | $336K | Buy |
4,050
+4,040
| +40,400% | +$335K | ﹤0.01% | 3539 |
|
|
2017
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 4622 |
|